COMMUNIQUÉS West-GlobeNewswire

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
11/04/2024
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for [...]
IMUNON Reports Compliance with Nasdaq Listing Requirements
11/04/2024
LAWRENCEVILLE, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) (“IMUNON” or the “Company”), a clinical-stage drug-development company focused on developing DNA-mediated immuno-oncology therapies [...]
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
11/04/2024
Published data shows that Ovaprene was safe and effective in a postcoital test study of 33 women Pivotal Phase 3 contraceptive efficacy clinical study of Ovaprene currently enrolling Ovaprene has the potential to be the [...]
Alignment Healthcare to Announce First Quarter 2024 Financial Results and Host Conference Call Thursday, May 2, 2024
11/04/2024
ORANGE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2024 financial results on Thursday, May 2, after market close. Following the release, the [...]
Inovalon Launches SDOH Market Insights SaaS Solution For Life Sciences To Elevate Health Equity Driven Engagement
11/04/2024
Empowering Life Sciences with Data Visualizations to Optimize Engagement, Enhance Patient Access, and Improve Population Health Outcomes BOWIE, Md., April 11, 2024 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of [...]
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
11/04/2024
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and [...]
Montauk Brewing Releases Its First Non-Alcoholic Brew: Montauk N.A. IPA
11/04/2024
Montauk Enters into the Golden Age of Non-Alcoholic Beer with A Better Tasting Non-Alcoholic Brew MONTAUK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Montauk Brewing Company (“Montauk Brewing” or “Montauk”), the leading [...]
Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
11/04/2024
PV-10 demonstrated significant anti-tumor activity in vivo in head and neck cancers KNOXVILLE, TN, April 11, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today [...]
GTG to pilot GeneType in Breast Screen centers across the U.S.
11/04/2024
MELBOURNE, Australia, April 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is [...]
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
11/04/2024
SEATTLE and VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of [...]
Poll: More Than Half of Black Birthers in Minnesota Feel Racial Bias and Lack of Access Leads to Greater Health Risks and Maternal Mortality
11/04/2024
Nearly half of those surveyed indicated that access to childcare and healthy foods had a positive impact on the maternal health of Black birthers MINNEAPOLIS, April 11, 2024 (GLOBE NEWSWIRE) -- While Minnesota ranks as [...]
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
11/04/2024
NGC-Cap demonstrated greater 5-FU exposure than monotherapy capecitabine at a significantly lower dose with a favorable clinical safety profile NGC-Cap holds potential for improved efficacy in more patients due to an [...]
BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of Nivelles
11/04/2024
PRESS RELEASE - PRIVILEGED INFORMATION A final circular of the creditors on the basis of XX 83/23 of the Economic Law Code (ELC) will take place before the Court grants authorisation, in accordance with article XX 83/26 [...]
BioSenic et son praticien de la restructuration (Me Yves Brulard) soumettent un plan de restructuration global engageant les années 2024-2030 au Tribunal de l’entreprise de Nivelles
11/04/2024
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE Une circularisation finale des créanciers sur base de XX 83/23 du Code de Droit Economique (CDE) va intervenir avant que le Tribunal n’autorise, conformément à l'article XX [...]
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
11/04/2024
Achieved initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients, which compares favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs Achieved initial cumulative MMR rate of 44 [...]
Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting
11/04/2024
NEW YORK and WALTHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
11/04/2024
MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of [...]
Theratechnologies fera une présentation à la 2024 Bloom Burton & Co. Healthcare Investor Conference
11/04/2024
MONTRÉAL, 11 avr. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au point et la commercialisation [...]
Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
11/04/2024
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]

Pages